Back to Search
Start Over
Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
- Source :
- Patient Preference and Adherence, Vol Volume 11, Pp 1253-1264 (2017)
- Publication Year :
- 2017
- Publisher :
- Dove Medical Press, 2017.
-
Abstract
- Sabrina Müller,1 Thomas Wilke,1 Andreas Fuchs,2 Ulf Maywald,2 Jan-Paul Flacke,3 Harald Heinisch,4 Klaus Krüger5 1Institute for Pharmacoeconomics and Medication Logistics, University of Wismar, Wismar, 2AOK PLUS, Dresden, 3Roche Pharma AG, Grenzach-Wyhlen, 4Chugai Pharma Europe Ltd, Frankfurt/M, 5Praxiszentrum St Bonifatius, Munich, Germany Objective: This study aimed to assess the level of nonpersistence (NP) and nonadherence (NA) to methotrexate (MTX) therapy in German patients with rheumatoid arthritis (RA). Materials and methods: Based on German claims data, RA patients who received a MTX therapy (subgroup: treatment-naive patients) were analyzed. NP was defined as treatment gap >12 weeks. Regarding NA, it is the overall medication possession ratio (MPR) during an observational period of 12 or 24 months after therapy, and the MPR is calculated only for the periods of therapy continuation; NA was defined as MPR
Details
- Language :
- English
- ISSN :
- 1177889X
- Volume :
- ume 11
- Database :
- Directory of Open Access Journals
- Journal :
- Patient Preference and Adherence
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.80b9d954b424976832f61dfba90875f
- Document Type :
- article